Immunomodulation of T- and NK-cell Responses by a Bispecific Antibody Targeting CD28 Homolog and PD-L1.
Cancer Immunol Res. 2022 Feb;10(2):200-214. doi: 10.1158/2326-6066.CIR-21-0218. Epub 2021 Dec 22.
Cancer Immunol Res. 2022.
PMID: 34937728